Nevada Gov. Joe Lombardo’s long-awaited health care policy proposal — initially hinted at in his January State of the State ...

Representatives Mark Green, MD, (R, Tenn.) and Kim Schrier, MD, (D-Wash.) reintroduced H.R. 2433, the Reducing Medically Unnecessary Delays in Care Act of 2025. The bill calls for additional ...

OHM Pharmacy Services, a Florida-based company operating under the names "Benzer" and "Auburndale," has pleaded guilty in a ...

One of the nation’s largest health insurers is reportedly the target of a Department of Justice investigation for alleged healthcare fraud.

For the many young adults living with diabetes, health insurance coverage transitions are not only stressful; they can also ...

Q1 2025 Earnings Call Transcript May 14, 2025ARS Pharmaceuticals, Inc. reports earnings inline with expectations.

In April 2025, Invivyd secured a $30 million non-dilutive term loan facility with Silicon Valley Bank, a division of First Citizens Bank, supporting balance sheet optionality and providing potential ...

Despite holding promise in a range of disease states, a variety of challenges prevent cell and gene therapies (CGTs) from ...

Health systems face an increasingly complex regulatory landscape with evolving rules on price transparency, prior authorization and Medicaid reimbursement, pushing revenue cycle teams to adapt swiftly ...

Discover ARS Pharmaceuticals' Q1 2025 performance as neffy gains momentum with $7.8M revenue, expanded insurance coverage, and a groundbreaking ...

Policymakers are increasingly focused on reforming prior authorization to reduce administrative burdens and improve patient ...

Swissmedic grants marketing authorization for PYLCLARI® in Switzerland b.e. Imaging is marketing authorization holder and has ...